Secondary Sclerosing Cholangitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Secondary Sclerosing Cholangitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT03566797

Secondary Sclerosis Cholangitis Prospective

SC-CIP is increasing in patients after critical illness. Pathogenesis is still largely unclear. Gut microbiome composition, gut permeability, bacterial transloc…

Austria380 participantsStarted 2018-07-20

All recent trials (5 shown)

Active — Not RecruitingNot Applicable

NCT02545309

Secondary Sclerosing Cholangitis in Critically Ill Patients

SSC-CIP is increasing in patients after critical illness. Pathogenesis is still largely unclear. The investigators hypothesize that genetic variants of biliary…

Austria140 participantsStarted 2015-12-21

TerminatedNot Applicable

NCT05396755

Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)

This is a randomized, open-label, controlled, parallel group, multicenter clinical trial. Patients with confirmed secondary sclerosing cholangitis (SSC-CIP) wil…

Germany1 participantsStarted 2022-11-14

Treatment: Endoscopic retrograde cholangiography (ERC)

Secondary Sclerosing Cholangitis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Secondary Sclerosis Cholangitis Prospective

All recent trials (5 shown)

Secondary Sclerosing Cholangitis in Critically Ill Patients

Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Secondary Sclerosis Cholangitis Prospective

All recent trials (5 shown)

Secondary Sclerosing Cholangitis in Critically Ill Patients

Biliary Interventions in Critically Ill Patients With Secondary Sclerosing Cholangitis (BISCIT)

SSC-COVID in Patients After COVID-19

The Effect of Bezafibrate on Cholestatic Itch